Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment
Sponsor: University of California, Berkeley
Summary
The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).
Official title: The Impact of Varenicline Nasal Spray 0.03mg Dry Eye Treatment on Ocular Surface Health, Tear Film Stability, and Ocular Discomfort
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
65
Start Date
2026-03-06
Completion Date
2026-12-31
Last Updated
2026-05-27
Healthy Volunteers
No
Conditions
Interventions
Varenicline 0.03Mg/Spray Nasal Soln
After meeting eligibility criteria and signing informed consent, participants will be dispensed a 3-month supply of varenicline 0.03mg/spray nasal solution. Participants will take the nasal spray home and spray once in each nostril twice daily for 3 months
Locations (1)
U.C. Berkeley Clinical Research Center
Berkeley, California, United States